Matrix metalloproteinases and cardiovascular diseases

Matrix metalloproteinases (MMPs) are extracellular enzymes that are important in many physiologic and pathologic processes. Their activity is regulated mainly by tissue inhibitors of metalloproteinases (TIMPs). MMPs expression is related with the classical cardiovascular risk factors as well as with...

Full description

Saved in:
Bibliographic Details
Published inHippokratia Vol. 13; no. 2; pp. 76 - 82
Main Authors Papazafiropoulou, A, Tentolouris, N
Format Journal Article
LanguageEnglish
Published Greece LITHOGRAPHIA Antoniadis I.-Psarras Th. G.P 01.04.2009
Subjects
Review
atherosclerosis
metalloproteinases
acute coronary syndromes
extracellular matrix
aneurysms
Online AccessGet full text

Cover

More Information
Summary:Matrix metalloproteinases (MMPs) are extracellular enzymes that are important in many physiologic and pathologic processes. Their activity is regulated mainly by tissue inhibitors of metalloproteinases (TIMPs). MMPs expression is related with the classical cardiovascular risk factors as well as with inflammation. They play a central role in atherosclerosis, plaque formation, platelet aggregation, acute coronary syndrome, restenosis, aortic aneurysms and peripheral vascular disease. Many studies have shown that commonly prescribed antihypertensive medications, glitazones and statins may influence MMPs activity. The aim of the review is to present literature data on the role of MMPs and their inhibitors in cardiovascular disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1108-4189
1790-8019